ScripVolatile Reactions To Benign Results Johnson & Johnson (J&J) kicked off the third-quarter earnings season for the life sciences with a mixed but generally positive reception. The company’s st
Medtech InsightJohnson & Johnson (Pty) Ltd has entered into a definite agreement to buy V-Wave Ltd. in a deal valued at potentially $1.7bn, which marks its second major deal in medtech this year, following the $